NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 113 filers reported holding NATERA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,678,000 | -41.7% | 139,582 | +33.8% | 0.00% | -40.0% |
| Q4 2021 | $9,741,000 | -39.1% | 104,303 | -27.4% | 0.01% | -44.4% |
| Q3 2021 | $16,001,000 | +64.1% | 143,585 | +67.2% | 0.01% | +80.0% |
| Q2 2021 | $9,751,000 | +5.0% | 85,886 | -6.1% | 0.01% | 0.0% |
| Q1 2021 | $9,286,000 | +1.6% | 91,454 | -0.4% | 0.01% | -16.7% |
| Q4 2020 | $9,138,000 | +79.4% | 91,819 | +30.2% | 0.01% | +50.0% |
| Q3 2020 | $5,093,000 | +67.9% | 70,497 | +15.8% | 0.00% | +100.0% |
| Q2 2020 | $3,034,000 | +280.7% | 60,855 | +128.0% | 0.00% | +100.0% |
| Q1 2020 | $797,000 | -43.0% | 26,689 | -35.7% | 0.00% | 0.0% |
| Q4 2019 | $1,399,000 | -18.1% | 41,523 | -20.3% | 0.00% | 0.0% |
| Q3 2019 | $1,708,000 | +572.4% | 52,073 | +322.3% | 0.00% | – |
| Q1 2019 | $254,000 | +56.8% | 12,331 | +6.0% | 0.00% | – |
| Q4 2018 | $162,000 | -88.2% | 11,631 | -79.7% | 0.00% | -100.0% |
| Q3 2018 | $1,371,000 | +3.5% | 57,282 | -18.6% | 0.00% | 0.0% |
| Q2 2018 | $1,324,000 | – | 70,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |